Bristol Myers Squibb opens new USD 100 million facility in Hyderabad
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-28 08:00 GMT | Update On 2024-03-21 09:56 GMT
Hyderabad: Bristol Myers Squibb, one of the world's largest biopharmaceutical companies, has announced the opening of a new facility in Hyderabad.
Invested over $100 million in the creation of this cutting-edge state-of-the-art facility, the company will expand its global drug development and IT & digital capabilities and is expected to be home to over 1,500 employees, the company said in a release.
The new site expands Bristol Myers Squibb’s global footprint and will serve as an innovation hub, as the company writes the next chapter in its history.
The facility was officially opened in the presence of Telangana Minister for Industries & Information Technology D Sridhar Babu.
Dr. Christopher Boerner, Chief Executive Officer, Bristol Myers Squibb and Greg Meyers, Chief Digital & Technology Officer, Bristol Myers Squibb, as well as several members of the Bristol Myers Squibb global and Hyderabad leadership teams were present at the event.
Speaking on the occasion, the Minister said “This marks an important milestone and investment in our vibrant community, offering opportunities for our rich talent pool here to work at the forefront of science and innovation.
I am proud of this strategic partnership with Bristol Myers Squibb, which brings new R&D and IT capabilities to Telangana. We have a wealth of remarkable talent in Telangana who will be able to contribute to important and impactful work at Bristol Myers Squibb. We are looking forward to our continued collaboration,” he said.
Christopher Boerner, said, “Our new innovation hub in Hyderabad will accelerate drug development and enhance our digital capabilities. This investment also enables us to further diversify our global workforce by adding world-class local talent and strengthening our ability to positively impact patients everywhere.”
“We are grateful for the ongoing collaboration with the Government of Telangana and are committed to working with them and supporting the local community as we continue to grow our company presence in India” he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.